Medicare Enrolled

Dr. Armand Fasano, M.D.

Ophthalmology · West New York, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
229 60TH ST, West New York, NJ 07093
2018690707
In practice since 2006 (20 years)
NPI: 1467487736 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fasano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fasano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fasano

Dr. Armand Fasano is an ophthalmology specialist in West New York, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fasano performed 6,650 Medicare services across 5,448 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fasano received a total of $4,536 from 22 pharmaceutical and/or device companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fasano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 14% volume in NJ $4,536 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,650
Medicare services
Top 14% in NJ for ophthalmology
5,448
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~332 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,223 $107 $356
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
720 $34 $131
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
639 $30 $208
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
631 $14 $84
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
483 $54 $150
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
462 $73 $248
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
366 $30 $90
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
304 $41 $140
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
279 $24 $77
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
271 $36 $143
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
224 $171 $769
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
128 $19 $85
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
120 $204 $600
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
119 $440 $1,300
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
116 $116 $426
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
112 $10 $30
Eye photography
Photographic imaging of the interior structures of the eye.
102 $20 $63
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
74 $285 $780
Insertion of drug delivery implant into tear duct
A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time.
74 $15 $100
Slit lamp examination of the eye
This procedure uses a specialized microscope to examine the front portion of the eye.
56 $33 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $99 $298
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
41 $1,268 $3,600
Incision to improve eye fluid flow
A surgical procedure involving an incision to enhance the drainage of fluid within the eye.
20 $752 $1,900
Eye deviation and range of motion exam
An examination to measure eye deviation and assess the range of motion of the eyes.
19 $56 $150
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
16 $571 $1,700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
22.6% medium
75.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,536
Total received (2018-2024)
Avg $648/year across 7 years
Top 20% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
190
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,536 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,125
2023
$954
2022
$662
2021
$227
2020
$359
2019
$617
2018
$593

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$331
SUN PHARMACEUTICAL INDUSTRIES INC.
$287
Bausch & Lomb Americas Inc.
$264
Tarsus Pharmaceuticals, Inc.
$127
Johnson & Johnson Surgical Vision, Inc.
$50
Harrow Eye, LLC
$34
Ocular Therapeutix, Inc.
$32
Top 3 companies account for 78.4% of 2024 payments
All-time payments by company (2018-2024) ›
Sun Pharmaceutical Industries Inc.
$978
Bausch & Lomb Americas Inc.
$542
Glaukos Corporation
$485
SUN PHARMACEUTICAL INDUSTRIES INC.
$324
Aerie Pharmaceuticals, Inc.
$263
Johnson & Johnson Surgical Vision, Inc.
$253
Bausch & Lomb, a division of Bausch Health US, LLC
$252
Shire North American Group Inc
$200
ABBVIE INC.
$174
Tarsus Pharmaceuticals, Inc.
$127
Kala Pharmaceuticals, Inc.
$121
Alcon Vision LLC
$116
Allergan Inc.
$108
Dompe US, Inc.
$108
Ocular Therapeutix, Inc.
$105
Novartis Pharmaceuticals Corporation
$101
Allergan, Inc.
$80
Genentech USA, Inc.
$69
Oyster Point Pharma, Inc.
$51
Harrow Eye, LLC
$34
Sight Sciences, Inc.
$25
BioTissue Holdings, Inc.
$19
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
BEPREVE · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Cequa · DEXTENZA · DURYSTA · EYSUVIS · INVELTYS · LOTEMAX SM · LUMIGAN · MIEBO · OMNI · OXERVATE · PROKERA · PROLENSA · RESTASIS · Rhopressa · Rocklatan · Simbrinza · TRAVATAN Z · TYRVAYA · Tecnis IOL · Tecnis Simplicity · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · iDose · iStent infinite Trabecular Micro-Bypass System Model iS3 · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in West New York?
Compare ophthalmologists in the West New York area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,378
Per 100K population
194.0
County median income
$90,032
Nearest hospital
PALISADES MEDICAL CENTER
1.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fasano is a mixed practice specialist, with above-average Medicare volume (top 14% in NJ), with low-engagement industry engagement in the top 20% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fasano experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Fasano performed 1,223 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fasano receive payments from pharmaceutical companies?
Yes. Dr. Fasano received a total of $4,536 from 22 companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fasano's costs compare to other ophthalmologists in West New York?
Dr. Fasano's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fasano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →